Received Jul 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | xx9n4 | — |
Expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 40-year-old female patient who received MMR (Priorix) solution for injection in pre-filled syringe (batch number xx9n4 with expiry date 01-JUN-2026) for prophylaxis. On 26-JUN-2026, the patient received Priorix. On 26-JUN-2026, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: Expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-JUN-2026 The registered pharmacist called in and reported that a patient had received an expired dose of Priorix.